ArticleFrontiers in oncology2021

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With

Jacob Handlos Grauslund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.